Clinic
Prime Healthcare Services Mesquite LLC
Prime Healthcare Services Mesquite LLC was paid $6.58M by Medicaid between Jan 2020 and Dec 2024, across 70 billing codes. Its largest line is 99285, emergency room visit (most serious) — 33% of everything it billed.
33Billing provider infoPRIME HEALTHCARE SERVICES MESQUITE LLC
MESQUITE, TX 75149
MESQUITE, TX 75149
33aNPI1790174860assigned 01/13/2015
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$6.58M
24GClaims131,829
24DCodes billed70
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#67 of 320
Median peer was paid$205K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 6,328 | $179K | |
| 2021 | 29,127 | $1.10M | |
| 2022 | 45,678 | $2.25M | |
| 2023 | 36,379 | $2.36M | |
| 2024incomplete | 14,317 | $689K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 33% | 5,737 | 5,331 | $2.14M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 7,143 | 6,755 | $1.67M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 20,355 | 19,633 | $1.37M |
| 80053 | Comprehensive metabolic panel | 1.7% | 8,094 | 7,406 | $112K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 967 | 920 | $109K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 6,917 | 3,383 | $97K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 3,507 | 3,235 | $93K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 9,481 | 8,575 | $80K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 2,954 | 2,564 | $77K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 1,098 | 1,031 | $67K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,981 | 1,748 | $65K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,017 | 2,881 | $58K |
58 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,365 | $50K |
| 81025 | <1% | 5,498 | $44K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 286 | $43K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,682 | $39K |
| 59025 | Fetal non-stress test | <1% | 589 | $38K |
| 87428 | <1% | 933 | $36K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 678 | $31K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,247 | $29K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,435 | $26K |
| 81001 | <1% | 6,359 | $24K | |
| 84484 | <1% | 2,346 | $24K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,574 | $24K |
| G0378 | Hospital observation service, per hour | <1% | 606 | $22K |
| 87070 | <1% | 2,223 | $22K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 413 | $20K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,296 | $18K |
| 83880 | <1% | 563 | $18K | |
| 83690 | <1% | 2,583 | $17K | |
| 76801 | <1% | 140 | $16K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 138 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,038 | $10K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,171 | $6K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 57 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 574 | $6K |
| 84702 | <1% | 308 | $5K | |
| 87420 | <1% | 252 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 702 | $4K |
| 81003 | <1% | 1,844 | $4K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 17 | $4K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 518 | $3K |
| 87088 | <1% | 462 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,391 | $3K |
| 83605 | <1% | 198 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,053 | $2K |
| 85610 | <1% | 689 | $2K | |
| 87186 | <1% | 213 | $2K | |
| 82550 | <1% | 257 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 16 | $2K |
| 87040 | <1% | 133 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 176 | $1K |
| 85730 | <1% | 195 | $883.20 | |
| 82947 | <1% | 88 | $848.60 | |
| 86901 | <1% | 210 | $611.74 | |
| 86900 | <1% | 210 | $609.13 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 97 | $577.17 |
| 85027 | <1% | 97 | $543.61 | |
| 80320 | <1% | 40 | $491.17 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,119 | $489.72 |
| 73630 | <1% | 14 | $458.13 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 274 | $257.57 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 154 | $221.29 |
| 82948 | <1% | 16 | $163.59 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 124 | $105.96 |
| 85007 | <1% | 44 | $83.57 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 327 | $38.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 22 | $14.93 |
| 82962 | <1% | 512 | $7.96 | |
| J3490 | Unclassified drugs | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREDDY, PREM (CHAIRMAN/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Prime Healthcare Services - Sherman Oaks, LLC | Sherman Oaks, CA | $5.68M |
| Prime Healthcare LA Palma, LLC | La Palma, CA | $3.02M |
| Paradise Valley Medical Group, INC. | National City, CA | $2.50M |
| Ohio Valley Home Care, LLC | East Liverpool, OH | $196K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.